HighTower Advisors
CSLT

HighTower Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

HighTower Advisors’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,497
Closed -$18K – 3785
2021
Q4 		$18K Sell
11,497
-2,000
-15% -$3.3K ﹤0.01% 3119
2021
Q3 		$22K Buy
13,497
+2,000
+17% +$3.92K ﹤0.01% 2994
2021
Q2 		$31K Hold
11,497
– – ﹤0.01% 2929
2021
Q1 		$18K Hold
11,497
– – ﹤0.01% 2906
2020
Q4 		$14K Hold
11,497
– – ﹤0.01% 2504
2020
Q3 		$13K Hold
11,497
– – ﹤0.01% 2405
2020
Q2 		$9K Hold
11,497
– – ﹤0.01% 2318
2020
Q1 		$8K Hold
11,497
– – ﹤0.01% 2134
2019
Q4 		$15K Hold
11,497
– – ﹤0.01% 2184
2019
Q3 		$16K Hold
11,497
– – ﹤0.01% 2285
2019
Q2 		$37K Buy
+11,497
New +$39.6K ﹤0.01% 2230

HighTower Advisors's CSLT Position: Q1 2022 in Review

HighTower Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 11,497 shares — an estimated $18K sold.

HighTower Advisors first reported a position in CSLT in Q2 2019 and held it in 11 quarters. The position peaked at $37K in Q2 2019. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • HighTower Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • HighTower Advisors sold 11,497 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $18K.
  • HighTower Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2019 and held it in 11 quarters.
  • HighTower Advisors's CASTLIGHT HEALTH, INC. position peaked at $37K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on HighTower Advisors's 13F filing for Q1 2022, filed 12 May 2022.